{
  "thread": {
    "uuid": "f0da69ab01fed7da338b2d93177d09f9885e9b2b",
    "url": "https://news.bloomberglaw.com/ip-law/novartis-fights-msns-push-to-delist-revived-entresto-patent",
    "site_full": "news.bloomberglaw.com",
    "site": "bloomberglaw.com",
    "site_section": "https://news.bgov.com/litigation",
    "site_categories": [
      "media"
    ],
    "section_title": "Litigation",
    "title": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
    "title_full": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
    "published": "2025-02-20T23:47:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://db0ip7zd23b50.cloudfront.net/dims4/default/521f1d9/2147483647/legacy_thumbnail/960x370%3E/quality/90/?url=http%3A%2F%2Fbloomberg-bna-brightspot.s3.amazonaws.com%2F72%2F46%2F480a82e746e39af2bf4fa9583055%2Fgettyimages-1647272651.jpg",
    "performance_score": 0,
    "domain_rank": 2190,
    "domain_rank_updated": "2025-02-17T23:00:00.000+02:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "f0da69ab01fed7da338b2d93177d09f9885e9b2b",
  "url": "https://news.bloomberglaw.com/ip-law/novartis-fights-msns-push-to-delist-revived-entresto-patent",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "Christopher Yasiejko",
  "published": "2025-02-20T23:47:00.000+02:00",
  "title": "Novartis Fights MSN's Push to Delist Revived Entresto Patent",
  "text": "MSN’s attempt to delist US Patent No. 8,101,659 from the US Food and Drug Administration’s registry of approved drugs is legally flawed because the underlying lawsuit concerns standard patent-infringement claims rather than Hatch-Waxman allegations, the Swiss drugmaker said Wednesday in a brief supporting its motion to dismiss in the US District Court for the District of Delaware. Novartis also separately asked the court to reject MSN’s ...\nLearn more about Bloomberg Law or Log In to keep reading:\nLearn About Bloomberg Law\nAI-powered legal analytics, workflow tools and premium legal & business news.\nAlready a subscriber?\nLog in to keep reading or access research tools.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Economy, Business and Finance"
  ],
  "topics": [
    "Health->drug rehabilitation",
    "Health->health organisation",
    "Economy, Business and Finance->healthcare industry",
    "Economy, Business and Finance->business governance"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [
      {
        "name": "US Food and Drug Administration",
        "sentiment": "negative"
      },
      {
        "name": "Novartis",
        "sentiment": "none"
      }
    ],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": "f0da69ab01fed7da338b2d93177d09f9885e9b2b",
    "first_syndicated": true
  },
  "trust": null,
  "rating": null,
  "crawled": "2025-02-21T00:06:02.221+02:00",
  "updated": "2025-02-21T00:06:02.221+02:00"
}